PROSPECTIVE STUDY ON ROLE OF CRP AS AN INFLAMMATORY MARKER IN TYPE-II DIABETES MELLITUS IN TERTIARY CARE HOSPITALAbstract
Globally at present, there are an estimated 366 million people affected with diabetes mellitus. The Indian figure is around 61.3 million diabetics, which is projected to cross 100 million by the year 2030. Owing to rise of diabetes mellitus cases, the economic burden due to diabetes in India ranks the highest in the world. With the increasing prevalence of diabetes, it has resulted in an increase in its complications which has resulted in increasing morbidity, mortality and health expenditure due to the requirement of specialized care. Diabetes Mellitus is one of the most prevalent chronic disorders in the modern world. CRP is a plasma protein which is not normally present in the body but its advent is marked by its elevated levels in the blood during certain specific condition, especially marked during the inflammatory events occurred as a result of any kind of injury. Due to its involvement in inflammation, which is also seen as one of the mediators of progression of type II diabetes mellitus and its various complications, it was suspected to be engrossed in their pathogenesis.
J. Shanmugapriya*, P. Geetha, V. S. Kumar and P. Shanmugasundaram
Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS) Pallavaram, Chennai, Tamil Nadu, India.
03 April, 2017
02 June, 2017
29 June, 2017
01 December, 2017